
Capivo Tablet
Marketer
Medicamen Biotech Ltd
Salt Composition
Capecitabine (150mg)
Overview Capivo Tablet
Oncaspar tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional applications may be determined by your physician. This medication is administered as part of a chemotherapy regimen, either singularly or in conjunction with other drugs. Oncaspar should be ingested with food, within 30 minutes post-meal. Dosage and frequency will be individualized by your doctor based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only upon your doctor's instruction. Common side effects include emesis, fatigue, nausea, abdominal discomfort, and diarrhea. This medication can suppress blood cell counts (specifically white blood cells), increasing infection risk. Regular blood work, including assessments of blood cell counts, cardiac function, liver health, and uric acid levels, is essential. Prior to initiating treatment, inform your physician of any pre-existing hepatic or renal conditions, and of all current medications, particularly those used to combat infections. Interactions with numerous other drugs are possible; therefore, complete medication disclosure is vital. This medication is contraindicated during gestation and lactation. The use of reliable contraception by both partners throughout the treatment period is strongly advised to prevent conception.
Uses of Capivo Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of Capivo Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Capivo Tablet should be administered with a meal.
Common Side effects of Capivo Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Capivo Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Capivo Tablet with a meal.
How Capivo Tablet works:
Capivo Tablet is a cancer treatment drug. Metabolic processes transform it into 5-fluorouracil, a substance that disrupts the production of cancerous cell genetic material (RNA and DNA). This disruption inhibits cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Capivo Tablet with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Capivo Tablet is contraindicated in pregnancy due to established risks to the fetus. In exceptional life-threatening circumstances, a physician may prescribe it when the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Lactation and Capivo Tablet use are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Capivo Tablet may cause drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should use Capivo Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Capivo Tablet is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should exercise caution when using Capivo tablets; dosage modification may be necessary. A physician's consultation is advised. Capivo tablets are contraindicated for individuals with severe renal dysfunction.
What if you forget to take Capivo Tablet :
NA
Facts to Know About Capivo Tablet
| Label | Value |
|---|---|
| Chemical Type | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Metabolic Antagonists |
